IL17A and kidney disorder: The systemic IL-17A infusion in C57BL/6 mice increased blood pressure and promoted the recruitment of inflammatory cells into the kidney, but, at the dose and time-points studied, this did not result in biochemical or histological evidence of kidney disease beyond inflammation.